|
Vericel Corp.
Ticker Symbol: VCEL CUSIP: 92346J108 Previous CUSIP: 00253U305 Exchange: NCM
Company's Online Profile
BUSINESS: Vericel Corp. is a leader in advanced therapies for the sports medicine and severe burn care markets. The company markets two cell therapy products in the United States. MACI® (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. The company also holds an exclusive license for North American commercial rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns.
|
IPO - 1/1/1900
Previous Ticker Symbol: ASTM Changed: 11/25/14
Previous Name: Aastrom Biosciences, Inc. Changed: 11/25/14
Mid Cap Stock -
Market Value $ 850 Million
Click for current VCEL price quote from the NASDAQ
Yahoo News Summary for VCEL
YAHOO! Profile for VCEL
Yahoo Detailed Quote
MarketWatch Quote
MSN Company Report for VCEL
Company's Online Information Links
|
Company's Online SEC EDGAR Filings |
Company's Email Address Links |
Address and Phone Numbers |
Address: 64 Sidney Sreet, Cambridge, MA 02139 |
Main Phone Number |
617-252-7999 |
Fax Number |
617-252-7550 |
Investor Relations
Lee Stern. Solebury Trout
|
646-378-2947
|
Toll Free Phone Number |
800-556-0311 |
CEO - Dominick C Colangelo |
CFO - Gerard J. Michel |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|